Apogee Therapeutics, Inc.
APGE
$39.94
$1.614.20%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/14/2025
-
MarketBeat
3/13/2025
-
The Fly
3/12/2025
-
MarketBeat
3/11/2025
-
MarketBeat
3/10/2025
-
Ticker Report
3/9/2025
-
Ticker Report
3/9/2025
-
MarketBeat
3/9/2025
-
MarketBeat
3/8/2025
-
MarketBeat
3/5/2025
-
MarketBeat
3/5/2025
-
Ticker Report
3/4/2025
-
GuruFocus
3/4/2025
-
TipRanks Financial Blog
3/3/2025
-
MarketBeat
3/3/2025
-
MarketBeat
3/3/2025
-
Benzinga
3/3/2025
-
MarketBeat
3/3/2025
-
The Fly
3/3/2025
-
GuruFocus
3/3/2025
-
GuruFocus
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 394 5230
Address
221 Crescent Street
Building 17 - Suite 102b
Waltham, MA 02453
Building 17 - Suite 102b
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary...
more
